Moderna’s stock tumbles after reported leak of data for cancer vaccine
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference.
Moderna and Merck are expected to share the Phase 3 data for their experimental cancer vaccine this weekend at a medical conference. This story matters for Finance & Markets readers tracking finance. Reported by marketwatch.com. Read the full original at the source link below.
Originally reported by marketwatch.com. FundingWire.com curates and briefs the finance & markets stories that matter. Our editorial policy →
Get the daily finance & markets signal